Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2024.12.06
ag真人平台官方：第六届董事会第十三次会议决议公告
2024.10.30
2024 THIRD QUARTERLY REPORT
2024.10.30
ag真人平台官方：2024年三季度报告
2024.10.17
DATE OF BOARD MEETING
2024.09.26
INTERIM REPORT 2024
2024.08.30
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
2024.08.30
ag真人平台官方：2024年半年度报告
2024.08.30
ag真人平台官方：2024年半年度报告摘要
2024.08.15
DATE OF BOARD MEETING
2024.07.12
POSITIVE PROFIT ALERT ANNOUNCEMENT FOR THE ESTIMATED 2024 INTERIM RESULTS
第一页
上一页
11
12
13
14
15
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
